Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation (IMAGE)

InSilico Medicine

Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation

Caption

The funds raised in this round will be directed to advance Insilico's innovative drug pipeline and AI platform developments.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.